BETA GLUCAN BASED PRODUCTS MARKET ANALYSIS

Global Beta Glucan Based Products Market – Global Industry Insights

Beta glucan is a valuable dietary ?ber present in cereal crops, especially in barley, oat, and some mushrooms. According to the EC Nutrition journal: August 2017, beta glucans polysaccharide naturally found in the bran of cereal grains such as barley and oats and to a much lesser degree in rye and wheat, in amounts of around 7%, 5%, 2%, and less than 1%, respectively, the cell wall of baker’s yeast, certain types of fungi, and various types of mushrooms.

Beta glucans promote health in a number of ways. Beta-glucans have been studied for their hypocholesterolemic effects. Furthermore, beta-1, 3-glucans improve the body’s immune system defense against foreign invaders by enhancing the ability of macrophages, neutrophils, and natural killer cells to respond to and fight bacteria, viruses, fungi, and parasites.

Moreover, growth of beta glucan based products market is attributed to increasing usage of beta-glucan as an immunity booster medicine in pharmaceutical and nutraceutical industry due to increasing demand for beta glucan in food & beverages and pharmaceuticals industry and increasing consciousness and concern about health & wellness among the global population. 

The global beta glucan based products market size was valued at US$ 455.4 Mn in 2017 and is expected to witness a CAGR of 7.2% during the forecast period (2018 – 2026).

Global Beta Glucan Based Products Market Share (%), By Source, 2018 & 2026

To learn more about this report, request sample copy

Source: Coherent Market Insights Analysis (2019)

Changing consumer preferences towards the use of nutritious food supplements over synthetic ingredients is expected to drive the market growth during the forecast period Beta glucan is gaining interest among the population due to its multiple functional and bioactive properties. Beta glucan shows beneficial role in reducing insulin resistance, dyslipidemia, hypertension, and obesity. A study published in the Today’s Dietitian Journal: May 2014 stated that overweight men who consumed 7 g/day of beta-glucan for 12 weeks experienced a significant reduction in body mass, waist circumference, and visceral fat compared to those in the placebo group. 

Subsequently, the application of β-glucan as a food ingredient is being widely considered with dual purposes of increasing the fiber content of food products and enhancing their health properties. As prevalence of cardiovascular disease (CVD) is increasing, identifying functional foods that reduce CVD risk factors (including high blood cholesterol) is an important area of research. Thus, oat β-glucan, a soluble dietary fiber found in the endosperm cell walls of oats,  has gained considerable interest due to its cholesterol-lowering properties.

In December 2010, the Dietetic Products, Nutrition and Allergies panel of the European Food Safety Authority (EFSA) approved a health claim linking consumption of 3g of oat beta glucans per day with improved cholesterol levels.

Global Beta Glucan Based Products Market Share (%), By Grade, 2018 & 2026

To learn more about this report, request sample copy

Source: Coherent Market Insights Analysis (2019)

Increasing application of beta glucans in various infectious disease treatments is further expected to aid in the market growth  

Various clinical and research studies support the application of beta glucan as a biological response modifier for the treatment of cancer and infectious diseases. However, the size and biochemical composition of β-glucans isolated from different sources affect their immunomodulatory properties.

Beta glucans are used in medical field to treat various diseases such as hyper cholesterolemia, diabetes, cancer, and HIV/AIDS. Beta glucans act as modulator for immune system. Moreover, it is used in the treatment of various cancers such as pulmonary malignancy, prostate cancer, and breast cancer. Beta glucans are also used for treatment of various types of diseases that are correlated with immune system infections.

• Beta glucan act as anti-cancer agent, owing to the reduction of reactive oxygen species, which protects DNA from damage, whereas secondary reason is that it inhibits growth and further transformation of cancer cells
• Oat beta glucan is a viscous, soluble fiber that can help maintain normal blood cholesterol and blood glucose levels as well as support gastrointestinal health
• Beta glucans are also used to prevent infections after surgery, using PGG-glucans, a specific blend of beta-glucans. It intravenously (by IV) reduces the risk of infection after surgery. Beta-glucans also reduces the risk of a serious infection called sepsis in trauma patients.

According to the Frontiers in Immunology Journal: April 2018, β-glucans has potent hematopoietic activity, which enhances the production of hematopoietic factors, bone marrow recovery as well as stem cell homing and engraftment.   

Among region, Europe is expected to be the most lucrative region in the beta glucan based products market. In Europe, beta glucan products are readily offered by several key players, thereby creating competition for delivering efficient beta glucan based products and thus, lowering overall cost, ensuring easy end user access.

Regulatory authorities are imposing regulations and streamlining approval process for product approvals and easier access. Increasing engagement of regulatory bodies in approving health claims is favoring adoption of beta glucan products in this market and this is expected to drive growth of the market in the region. For instance, in November 2017, Council of the European Union authorized an extension of use of yeast beta-glucans as a novel food ingredient under Regulation (EC) No 258/97.

In November 2011, Commission Implementing Decision (EU) authorized, in accordance with Regulation (EC) No 258/97, stating that yeast beta-glucans as a novel food ingredient to be used in certain foods and foodstuffs, including beverages as well as in food supplements and in food for special medical purposes and total diet replacement for weight control.   

Key players operating in the beta glucan based products market include Jkosmmune, Lesaffre Group, Merck KGaA, Garuda International, Inc., Ohly GmBH, Koninklijke DSM N.V., Kerry Group PLC, STR Biotech Co. Ltd., Macrocare Tech Co., Ltd., Amarte USA, LLC, Ceapro Inc., Biotec Pharmacon ASA, Quegen Biotech Co., Ltd., Kemin Industries, Inc., NutraQ AS, Lantmännen, Carbon Medical Technologies, Inc., Givaudan SA, Danaher Corporation, Super Beta Glucan Inc. and AIPPO.